Naltrexone for Alcohol Use Disorder in Cirrhosis: Bridging the Gap in an Understudied Population
Saved in:
| Published in | Journal of clinical and experimental hepatology Vol. 15; no. 2; p. 102509 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
India
Elsevier B.V
01.03.2025
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| ArticleNumber | 102509 |
|---|---|
| Author | Marti-Aguado, David Bataller, Ramón Vergara-Quispe, Romina |
| Author_xml | – sequence: 1 givenname: Romina orcidid: 0000-0003-3828-1410 surname: Vergara-Quispe fullname: Vergara-Quispe, Romina organization: Liver Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain – sequence: 2 givenname: David surname: Marti-Aguado fullname: Marti-Aguado, David organization: Digestive Disease Department, Clinic University Hospital, INCLIVA Health Research Institute, Valencia, Spain – sequence: 3 givenname: Ramón surname: Bataller fullname: Bataller, Ramón email: bataller@clinic.cat organization: Liver Unit, Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40027174$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkDtvWyEYQBkcNW6aP9ChYsxih8d9Wl1cp3lIVtuhnikXPmwcDA7cGzX_PlhOOmRoWJDgnE9wPqKRDx4Q-kzJlBJaXW6nWwWbKSOszAesJO0IjUlb80nVNPwUnae0JXlVhBWEfUCnBSGspnUxRn9-SNdH-JsHYhMinjsVNsHhVQJ8ZVOIGiK2Hi9sjJuQbJrhb9HqtfVr3G8A38j94Vp6vPIZTf2gLWj8K-wHJ3sb_Cd0YqRLcP6yn6HV9fffi9vJ8ufN3WK-nCjWNP2E67Jjre46k19ZthUzxvBSkqKTRdMqWnVVUxYtlQ1XdVHxhjGp6s6YknPJVMXP0MVx7j6GhwFSL3Y2KXBOeghDEpzWvCC0rFlGv7ygQ7cDLfbR7mR8Eq9VMsCOgIohpQjmH0KJOBQXW3EoLg7FxbF4lr4eJci_fLQQRVIWvAJtI6he6GD_r8_e6MpZb5V09_D0nvwMLnqdEg |
| Cites_doi | 10.1016/S2468-1253(19)30349-8 10.1016/j.jhep.2023.03.017 10.1111/apt.17888 10.1097/HC9.0000000000000093 10.3389/fpsyt.2018.00708 10.14309/ajg.0000000000002572 10.1016/j.cgh.2020.10.026 10.1097/HEP.0000000000000570 10.1016/j.jceh.2024.102447 10.1007/s40429-023-00535-x 10.1016/j.cgh.2022.08.001 10.1016/j.aohep.2023.101162 10.1016/j.cgh.2015.07.047 10.1002/hep4.2080 10.4103/psychiatry.IndianJPsychiatry_201_19 10.1002/hep.31042 10.1016/j.phrs.2024.107454 10.1016/j.eclinm.2023.102046 10.1001/jamanetworkopen.2024.52459 |
| ContentType | Journal Article |
| Copyright | 2025 |
| Copyright_xml | – notice: 2025 |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1016/j.jceh.2025.102509 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| ExternalDocumentID | 40027174 10_1016_j_jceh_2025_102509 S097368832500009X |
| Genre | Editorial Commentary |
| GroupedDBID | --- --K --M -RU .1- .FO .~1 0R~ 1P~ 1~. 1~5 4.4 457 4G. 53G 7-5 AAEDT AAEDW AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABJNI ABMAC ABMZM ABWVN ACDAQ ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX AOIJS APXCP AXJTR BAWUL BKOJK BLXMC BNPGV DIK EBS EFJIC EFKBS EJD FDB FEDTE FIRID FNPLU FYGXN GBLVA HVGLF HYE HZ~ KOM M41 MO0 O-L O9- OAUVE OC. OK1 ON0 P-8 P-9 PC. Q38 ROL RPM SDF SPCBC SSH SSZ T5K Z5R ~G- AFCTW AGRNS RIG AAYXX CITATION NPM 7X8 |
| ID | FETCH-LOGICAL-c288t-3d5b29dbbf0605962fff35a04ba489c16b685491a83c7463822ac7bff533a2c63 |
| IEDL.DBID | .~1 |
| ISSN | 0973-6883 |
| IngestDate | Fri Jul 11 16:18:47 EDT 2025 Mon Jul 21 05:32:17 EDT 2025 Sun Jul 06 05:08:00 EDT 2025 Sat Jun 28 18:16:45 EDT 2025 Tue Aug 26 16:52:16 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | AUD MAUD DILI FDA AH RUCAM EMA ALD EtG PEth WHO |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c288t-3d5b29dbbf0605962fff35a04ba489c16b685491a83c7463822ac7bff533a2c63 |
| Notes | SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1 |
| ORCID | 0000-0003-3828-1410 |
| PMID | 40027174 |
| PQID | 3173401572 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3173401572 pubmed_primary_40027174 crossref_primary_10_1016_j_jceh_2025_102509 elsevier_sciencedirect_doi_10_1016_j_jceh_2025_102509 elsevier_clinicalkey_doi_10_1016_j_jceh_2025_102509 |
| PublicationCentury | 2000 |
| PublicationDate | March-April 2025 2025-03-00 2025 Mar-Apr 20250301 |
| PublicationDateYYYYMMDD | 2025-03-01 |
| PublicationDate_xml | – month: 03 year: 2025 text: March-April 2025 |
| PublicationDecade | 2020 |
| PublicationPlace | India |
| PublicationPlace_xml | – name: India |
| PublicationTitle | Journal of clinical and experimental hepatology |
| PublicationTitleAlternate | J Clin Exp Hepatol |
| PublicationYear | 2025 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Varshney, Kaur, Sarin, Shasthry, Arora (bib23) 2025 Mar-Apr; 15 Alvarado-Tapias, Pose, Gratacós, Clemente-Sánchez, López-Pelayo, Bataller (bib2) 2024 Oct Hernández-Évole, Jiménez-Esquivel, Pose, Bataller (bib6) 2024 Jan-Feb; 29 Agabio, Lopez-Pelayo, Bruguera (bib13) 2024 Nov; 209 Kumar, Sharma, Bansal, Bahetra, Gill, Kumar (bib25) 2020 Nov-Dec; 62 Thompson, Taddei, Kaplan, Rabiee (bib22) 2024 Apr; 6 (bib8) 2024 Jophlin, Singal, Bataller (bib17) 2024 Jan 1; 119 Rogal, Youk, Zhang (bib18) 2020 Jun; 71 Juanola, Pose, Ginès (bib4) 2024 Dec Rabiee, Mahmud, Falker, Garcia-Tsao, Taddei, Kaplan (bib19) 2023 Mar; 7 Devarbhavi, Asrani, Arab, Nartey, Pose, Kamath (bib1) 2023 Aug; 79 (bib24) 2004 Marti-Aguado, Gougol, Gomez-Medina (bib9) 2023 Jun 22; 61 Sepanlou, Safiri, Bisignano (bib3) 2020 Mar; 5 Vannier, Przybyszewski, Shay (bib11) 2023 Jun; 21 Im, Mellinger, Winters (bib20) 2021 Nov; 19 Ayyala, Bottyan, Tien (bib21) 2022 Dec; 6 De Beaurepaire, Sinclair, Heydtmann (bib15) 2019 Jan; 9 Gratacós-Ginès, Bruguera, Pérez-Guasch (bib16) 2024 Feb; 79 Flemming, Djerboua, Chapman, Ayonrinde, Terrault (bib5) 2024 Dec 2; 7 Khan, Tansel, White (bib12) 2016 Feb; 14 Lim, Tay, Ng (bib10) 2024 Mar; 59 (bib7) 2022 Kirsch, Belnap, Burnette, Grodin, Ray (bib14) 2024; 11 Vannier (10.1016/j.jceh.2025.102509_bib11) 2023; 21 De Beaurepaire (10.1016/j.jceh.2025.102509_bib15) 2019; 9 Hernández-Évole (10.1016/j.jceh.2025.102509_bib6) 2024; 29 (10.1016/j.jceh.2025.102509_bib7) 2022 Thompson (10.1016/j.jceh.2025.102509_bib22) 2024; 6 Agabio (10.1016/j.jceh.2025.102509_bib13) 2024; 209 Juanola (10.1016/j.jceh.2025.102509_bib4) 2024 Im (10.1016/j.jceh.2025.102509_bib20) 2021; 19 Devarbhavi (10.1016/j.jceh.2025.102509_bib1) 2023; 79 Lim (10.1016/j.jceh.2025.102509_bib10) 2024; 59 Jophlin (10.1016/j.jceh.2025.102509_bib17) 2024; 119 Rogal (10.1016/j.jceh.2025.102509_bib18) 2020; 71 (10.1016/j.jceh.2025.102509_bib24) 2004 Gratacós-Ginès (10.1016/j.jceh.2025.102509_bib16) 2024; 79 Khan (10.1016/j.jceh.2025.102509_bib12) 2016; 14 Rabiee (10.1016/j.jceh.2025.102509_bib19) 2023; 7 Ayyala (10.1016/j.jceh.2025.102509_bib21) 2022; 6 Alvarado-Tapias (10.1016/j.jceh.2025.102509_bib2) 2024 Kirsch (10.1016/j.jceh.2025.102509_bib14) 2024; 11 Varshney (10.1016/j.jceh.2025.102509_bib23) 2025; 15 (10.1016/j.jceh.2025.102509_bib8) 2024 Kumar (10.1016/j.jceh.2025.102509_bib25) 2020; 62 Flemming (10.1016/j.jceh.2025.102509_bib5) 2024; 7 Marti-Aguado (10.1016/j.jceh.2025.102509_bib9) 2023; 61 Sepanlou (10.1016/j.jceh.2025.102509_bib3) 2020; 5 |
| References_xml | – volume: 14 start-page: 191 year: 2016 Feb end-page: 202 ident: bib12 article-title: Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review publication-title: Clin Gastroenterol Hepatol – volume: 9 start-page: 708 year: 2019 Jan ident: bib15 article-title: The use of baclofen as a treatment for alcohol use disorder: a clinical practice perspective publication-title: Front Psychiatr – volume: 29 year: 2024 Jan-Feb ident: bib6 article-title: Alcohol-associated liver disease: epidemiology and management publication-title: Ann Hepatol – volume: 59 start-page: 730 year: 2024 Mar end-page: 741 ident: bib10 article-title: Meta-analysis: prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis publication-title: Aliment Pharmacol Ther – volume: 71 start-page: 2080 year: 2020 Jun end-page: 2092 ident: bib18 article-title: Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis publication-title: Hepatology – volume: 15 year: 2025 Mar-Apr ident: bib23 article-title: Safety and effectiveness of naltrexone in the management of alcohol use disorder in patients with alcohol-associated cirrhosis: first clinical observation from Indian cohort publication-title: J Clin Exp Hepatol – volume: 19 start-page: 2407 year: 2021 Nov end-page: 2416.e8 ident: bib20 article-title: Provider attitudes and practices for alcohol screening, treatment, and education in patients with liver disease: a survey from the American Association for the Study of Liver Diseases alcohol-associated liver disease special interest group publication-title: Clin Gastroenterol Hepatol – volume: 6 start-page: 3433 year: 2022 Dec end-page: 3442 ident: bib21 article-title: Naltrexone for alcohol use disorder: hepatic safety in patients with and without liver disease publication-title: Hepatol Commun – volume: 6 year: 2024 Apr ident: bib22 article-title: Safety of naltrexone in patients with cirrhosis publication-title: JHEP Rep – volume: 209 year: 2024 Nov ident: bib13 article-title: Efficacy of medications for the treatment of alcohol use disorder (AUD): a systematic review and meta-analysis considering baseline AUD severity publication-title: Pharmacol Res – volume: 79 start-page: 516 year: 2023 Aug end-page: 537 ident: bib1 article-title: Global burden of liver disease: 2023 update publication-title: J Hepatol – year: 2024 Dec ident: bib4 article-title: Liver Cirrhosis: ancient disease, new challenge publication-title: Med Clin (Barc) – volume: 5 start-page: 245 year: 2020 Mar end-page: 266 ident: bib3 article-title: The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet Gastroenterol Hepatol – volume: 7 year: 2024 Dec 2 ident: bib5 article-title: Epidemiology and outcomes of alcohol-associated hepatitis in adolescents and young adults publication-title: JAMA Netw Open – year: 2024 Oct ident: bib2 article-title: Alcohol-associated liver disease: natural history, management and novel targeted therapies publication-title: Clin Mol Hepatol – year: 2024 ident: bib8 publication-title: Global Status Report on Alcohol and Health and Treatment of Substance Use Disorders – volume: 61 year: 2023 Jun 22 ident: bib9 article-title: Prevalence and clinical impact of alcohol withdrawal syndrome in alcohol-associated hepatitis and the potential role of prophylaxis: a multinational, retrospective cohort study publication-title: EClinicalMedicine – volume: 7 year: 2023 Mar ident: bib19 article-title: Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis publication-title: Hepatol Commun – year: 2004 ident: bib24 article-title: Bethesda (MD): National Library of Medicine (US) – year: 2022 ident: bib7 publication-title: Diagnostic and Statistical Manual of Mental Disorders – volume: 21 start-page: 1571 year: 2023 Jun end-page: 1580.e7 ident: bib11 article-title: Psychotherapy for alcohol use disorder is associated with reduced risk of incident alcohol-associated liver disease publication-title: Clin Gastroenterol Hepatol – volume: 79 start-page: 368 year: 2024 Feb end-page: 379 ident: bib16 article-title: Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: results from a systematic review and meta-analysis publication-title: Hepatology – volume: 119 start-page: 30 year: 2024 Jan 1 end-page: 54 ident: bib17 article-title: ACG clinical guideline: alcohol-associated liver disease publication-title: Am J Gastroenterol – volume: 11 start-page: 81 year: 2024 end-page: 93 ident: bib14 article-title: Pharmacological treatments for alcohol use disorder: considering the role of sex and gender publication-title: Curr Addict Rep – volume: 62 start-page: 650 year: 2020 Nov-Dec end-page: 658 ident: bib25 article-title: A comparative study on the safety and efficacy of naltrexone versus baclofen versus acamprosate in the management of alcohol dependence publication-title: Indian J Psychiatr – volume: 5 start-page: 245 year: 2020 ident: 10.1016/j.jceh.2025.102509_bib3 article-title: The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 publication-title: Lancet Gastroenterol Hepatol doi: 10.1016/S2468-1253(19)30349-8 – volume: 79 start-page: 516 year: 2023 ident: 10.1016/j.jceh.2025.102509_bib1 article-title: Global burden of liver disease: 2023 update publication-title: J Hepatol doi: 10.1016/j.jhep.2023.03.017 – volume: 59 start-page: 730 year: 2024 ident: 10.1016/j.jceh.2025.102509_bib10 article-title: Meta-analysis: prevalence and impact of alcohol abstinence in alcohol-associated cirrhosis publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.17888 – volume: 7 year: 2023 ident: 10.1016/j.jceh.2025.102509_bib19 article-title: Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis publication-title: Hepatol Commun doi: 10.1097/HC9.0000000000000093 – volume: 9 start-page: 708 year: 2019 ident: 10.1016/j.jceh.2025.102509_bib15 article-title: The use of baclofen as a treatment for alcohol use disorder: a clinical practice perspective publication-title: Front Psychiatr doi: 10.3389/fpsyt.2018.00708 – volume: 119 start-page: 30 year: 2024 ident: 10.1016/j.jceh.2025.102509_bib17 article-title: ACG clinical guideline: alcohol-associated liver disease publication-title: Am J Gastroenterol doi: 10.14309/ajg.0000000000002572 – volume: 19 start-page: 2407 year: 2021 ident: 10.1016/j.jceh.2025.102509_bib20 article-title: Provider attitudes and practices for alcohol screening, treatment, and education in patients with liver disease: a survey from the American Association for the Study of Liver Diseases alcohol-associated liver disease special interest group publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2020.10.026 – year: 2022 ident: 10.1016/j.jceh.2025.102509_bib7 – volume: 6 year: 2024 ident: 10.1016/j.jceh.2025.102509_bib22 article-title: Safety of naltrexone in patients with cirrhosis publication-title: JHEP Rep – volume: 79 start-page: 368 year: 2024 ident: 10.1016/j.jceh.2025.102509_bib16 article-title: Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: results from a systematic review and meta-analysis publication-title: Hepatology doi: 10.1097/HEP.0000000000000570 – volume: 15 year: 2025 ident: 10.1016/j.jceh.2025.102509_bib23 article-title: Safety and effectiveness of naltrexone in the management of alcohol use disorder in patients with alcohol-associated cirrhosis: first clinical observation from Indian cohort publication-title: J Clin Exp Hepatol doi: 10.1016/j.jceh.2024.102447 – volume: 11 start-page: 81 year: 2024 ident: 10.1016/j.jceh.2025.102509_bib14 article-title: Pharmacological treatments for alcohol use disorder: considering the role of sex and gender publication-title: Curr Addict Rep doi: 10.1007/s40429-023-00535-x – volume: 21 start-page: 1571 year: 2023 ident: 10.1016/j.jceh.2025.102509_bib11 article-title: Psychotherapy for alcohol use disorder is associated with reduced risk of incident alcohol-associated liver disease publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2022.08.001 – year: 2024 ident: 10.1016/j.jceh.2025.102509_bib2 article-title: Alcohol-associated liver disease: natural history, management and novel targeted therapies publication-title: Clin Mol Hepatol – volume: 29 year: 2024 ident: 10.1016/j.jceh.2025.102509_bib6 article-title: Alcohol-associated liver disease: epidemiology and management publication-title: Ann Hepatol doi: 10.1016/j.aohep.2023.101162 – volume: 14 start-page: 191 year: 2016 ident: 10.1016/j.jceh.2025.102509_bib12 article-title: Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review publication-title: Clin Gastroenterol Hepatol doi: 10.1016/j.cgh.2015.07.047 – year: 2024 ident: 10.1016/j.jceh.2025.102509_bib4 article-title: Liver Cirrhosis: ancient disease, new challenge publication-title: Med Clin (Barc) – year: 2004 ident: 10.1016/j.jceh.2025.102509_bib24 – volume: 6 start-page: 3433 year: 2022 ident: 10.1016/j.jceh.2025.102509_bib21 article-title: Naltrexone for alcohol use disorder: hepatic safety in patients with and without liver disease publication-title: Hepatol Commun doi: 10.1002/hep4.2080 – volume: 62 start-page: 650 year: 2020 ident: 10.1016/j.jceh.2025.102509_bib25 article-title: A comparative study on the safety and efficacy of naltrexone versus baclofen versus acamprosate in the management of alcohol dependence publication-title: Indian J Psychiatr doi: 10.4103/psychiatry.IndianJPsychiatry_201_19 – volume: 71 start-page: 2080 year: 2020 ident: 10.1016/j.jceh.2025.102509_bib18 article-title: Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis publication-title: Hepatology doi: 10.1002/hep.31042 – year: 2024 ident: 10.1016/j.jceh.2025.102509_bib8 – volume: 209 year: 2024 ident: 10.1016/j.jceh.2025.102509_bib13 article-title: Efficacy of medications for the treatment of alcohol use disorder (AUD): a systematic review and meta-analysis considering baseline AUD severity publication-title: Pharmacol Res doi: 10.1016/j.phrs.2024.107454 – volume: 61 year: 2023 ident: 10.1016/j.jceh.2025.102509_bib9 article-title: Prevalence and clinical impact of alcohol withdrawal syndrome in alcohol-associated hepatitis and the potential role of prophylaxis: a multinational, retrospective cohort study publication-title: EClinicalMedicine doi: 10.1016/j.eclinm.2023.102046 – volume: 7 year: 2024 ident: 10.1016/j.jceh.2025.102509_bib5 article-title: Epidemiology and outcomes of alcohol-associated hepatitis in adolescents and young adults publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2024.52459 |
| SSID | ssj0000602402 |
| Score | 2.3182952 |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 102509 |
| Title | Naltrexone for Alcohol Use Disorder in Cirrhosis: Bridging the Gap in an Understudied Population |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S097368832500009X https://dx.doi.org/10.1016/j.jceh.2025.102509 https://www.ncbi.nlm.nih.gov/pubmed/40027174 https://www.proquest.com/docview/3173401572 |
| Volume | 15 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF5CAqWXkqQv58UWcguqrX1KuTmmidsSU2gNvm13pV2iEGRjO5BTfntntJKhkKaQox6DltnRzDc7L0JO81yXLC1lEnxuE6ElS5zUaWILsDfBDWRW4nnH9USNp-LbTM62yKirhcG0ylb3R53eaOv2Tr_lZn9RVf2f2GhGZSCRsgE6M6xgFxql_PNjujlnGSjs4tUEE-D9BAna2pmY5nVbeIxJMIlNDCTmJT5tn_6FPxs7dLlL3rQAkg7jGvfIlq_3yavrNkT-lvye2Lv10j_Ma08BkNJhnIFLpytPu1abtKrpqFoub-aranVOL7BoC0wYBTBIr-wCH9uaTmPdC-YZlvTHZtDXOzK9_PJrNE7aMQpJwbJsnfBSOpaXzgXgBQ7bCSFwaQfCWZHlRaqcysBLTG3GCy3gf2TMFtqFAEjQskLx92S7hkV_JFQPrM90yblXSqg0OM24UIqVArxI52WPnHXMM4vYLcN0aWS3BlltkNUmsrpHeMdf09WBguYyoMyfpZIbqr8k5b90n7otNPALYVzE1n5-vzIAoTi4mVKzHvkQ93azeoF-O3htBy_86iF5jVcxa-2IbK-X9_4YYMzanTRyekJ2hl-_jyd_ACfO7gI |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1baxQxFD7UCuqLeHfrLYI-ybg7uc4IPtRq3druItiFfUuTmQSnlNllZ4v64p_yD3oymVkQvIDQ1wnJhC8n55JzA3iW56qkaSkS73KTcCVoYoVKE1OgvPF2JLIyvHdMpnI84x_mYr4FP_pcmBBW2fH-yNNbbt19GXZoDpdVNfwUCs3IDClStIrOvIusPHTfvqDd1rw-eIuH_JzS_XfHe-Okay2QFDTL1gkrhaV5aa0fybYBjfeeCTPi1vAsL1JpZYaWU2oyViiONEqpKZT1HrUjQwvJcN1LcJkjuwhtE15-TzcPO7hg8Fi0Nf4US8IOu2SdGFd2WrjgBKEiVE0QIRDy9wLxTwpvK_j2b8D1TmMluxGUm7Dl6ltwZdL55G_DydScrVfu66J2BDVgshub7pJZ40hf25NUNdmrVqvPi6ZqXpE3IUsMZSZB7ZO8N8swbGoyi4k2IbCxJB83ncXuwOxCwL0L2zVu-j4QNTIuUyVjTkouU28VZVxKWnI0W60TA3jRg6eXsTyH7uPWTnWAWgeodYR6AKzHV_eJp8gqNUqPv84Sm1m_kOY_5z3tj1DjnQ2OGFO7xXmjUWdjaNcKRQdwL57tZvc8PBSgmbjzn399AlfHx5MjfXQwPXwA18JIDJl7CNvr1bl7hDrU2j5uaZbAyUVfkp-JeCkl |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Naltrexone+for+Alcohol+Use+Disorder+in+Cirrhosis%3A+Bridging+the+Gap+in+an+Understudied+Population&rft.jtitle=Journal+of+clinical+and+experimental+hepatology&rft.au=Vergara-Quispe%2C+Romina&rft.au=Marti-Aguado%2C+David&rft.au=Bataller%2C+Ram%C3%B3n&rft.date=2025-03-01&rft.issn=0973-6883&rft.volume=15&rft.issue=2&rft.spage=102509&rft_id=info:doi/10.1016%2Fj.jceh.2025.102509&rft_id=info%3Apmid%2F40027174&rft.externalDocID=40027174 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0973-6883&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0973-6883&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0973-6883&client=summon |